RECENT NEWS

Urgent action is required to reduce the devastating impact of surgical site infections (SSIs) in the UK, according to the report entitled ‘Time to Act: A State of the Nation Report on Surgical Site Infections in the UK’.

CliniSys Group has formed a partnership with Software Testing Solutions (STS) that will support CliniSys’ delivery of automated software testing services for its WinPath Enterprise LIMS and ICE solutions.

In the third article in his series on method comparisons, Stephen MacDonald focuses on what differences are expected and acceptable, and what other factors need further investigation. Read the full feature in the December issue.

Triaging patients presenting with acute respiratory infection symptoms in the influenza season can be a minefield, without the added pressure of a global pandemic. Distinguishing between viral and bacterial infections can inform treatment decisions.

Ibex Medical Analytics has announced a research partnership and joint study with Institut Curie, France’s leading cancer centre, for the first-ever blinded and independent evaluation of an AI solution for breast cancer detection.

Agilent Technologies has launched the Biomarker Pathologist Training Programme, a global initiative created to empower pathologists to score biomarkers accurately and confidently.

A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papillomavirus (HPV) has emerged, based on a highly specific point-of-care blood test that appears to indicate cancer, and predict its course.

The Galleri blood test, developed by GRAIL, can detect early-stage cancers through a simple blood test, and will be piloted with 165,000 patients in a world-first deal struck by NHS England.

Although John Cooper originally trained in veterinary science, he has always enjoyed working with those from other disciplines. Here, he puts the case for One Health and how this approach could be beneficial when facing new challenges in the future.

Torrey Pines Scientific has announced it new EchoTherm Stackable/Programmable Vibration-Free Chilling Incubators for protein crystallography and other life science uses.

The SHOT team will host its final webinar of 2020 on 2 December at 14:00 GMT, covering the Febrile, Allergic and Hypotensive Reactions (FAHR) chapter of the Annual SHOT Report 2019, along with a seven-year trend analysis.

INTEGRA Biosciences has compiled a series of videos to demonstrate how the company’s lightweight VIAFLO electronic pipette and VOYAGER adjustable tip spacing pipette can make daily pipetting tasks easier and faster.

The Biomedical Science Industry Handbook 2021 will be circulated with the December issue of Pathology in Practice, providing comprehensive information on the full range of products and services available from the in vitro diagnostics (IVD) industry.

FFEI, a global developer of award-winning digital imaging solutions, has launched the Sierra Validate & Standardise (VS) Analyser, the latest product available within the patented Sierra colour calibration technology portfolio.

The Health and Care Professions Council (HCPC) has called for greater recognition of health and care professionals, and is asking government and the public to remember the sentiments expressed towards all key workers during the first lockdown.

Elsevier has published a new book in the area of biomedical science. ‘Entitled Human Physiology in Extreme Environments’, this is a second edition of the title written by Hanns-Christian Gunga.

NanoString Technologies has announced a collaboration with Oregon Health & Science University (OHSU) for the development of novel GeoMx Digital Spatial Profiler (DSP) protein assays to profile breast cancer.

Proscia has announced that NASA’s Jet Propulsion Laboratory (JPL) and the National Cancer Institute Consortium for Molecular Characterization of Screen-Detected Lesions (MCL), have used Proscia’s Concentriq platform to advance biomedical research.

Hologic has announced the CE-marking of its Genius Digital Diagnostics System, the first digital cytology platform that combines a new artificial intelligence (AI) algorithm with digital imaging to identify precancerous lesions and cancer cells.

Scientists in Bristol have worked with CliniSys to develop information technology (IT) to support critical newborn screening and tissue typing services.